Concurrent Skin Reduction in Nipple Sparing Mastectomy and Immediate Tissue Expander Reconstruction for Grade Three Ptosis Breasts
Journal of Aesthetic & Reconstructive Surgery · 2016
DOI: 10.4172/2472-1905.100013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Aesthetic & Reconstructive Surgery, 2016. Verfasst von Hubert B Shih und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
and Immediate Tissue Expander Reconstruction for Grade Three Ptosis Breasts two breasts had skin flap necrosis with one of these, requiring expander explantation, while three breasts suffered from partial NAC necrosis.We report a technique used in two patients with grade three ptosis whereby an initial NAC devascularization procedure is performed, followed four weeks later with NSM and skin reduction using either a Wise or peri-areolar pattern de-epithelialization and infolding technique, and placement of a tissue expander.With this method, there have been no complications with NAC or skin viability. MethodPatients are deemed acceptable candidates for NSM from an oncologic perspective [3,4] and are evaluated by the plastic surgeon.The reconstructive options are discussed, including both
Zitieren
APA
Shih, H. B., & BS, A. S. (2016). Concurrent Skin Reduction in Nipple Sparing Mastectomy and Immediate Tissue Expander Reconstruction for Grade Three Ptosis Breasts. Journal of Aesthetic & Reconstructive Surgery. https://doi.org/10.4172/2472-1905.100013
Vancouver
Shih HB, BS AS. Concurrent Skin Reduction in Nipple Sparing Mastectomy and Immediate Tissue Expander Reconstruction for Grade Three Ptosis Breasts. Journal of Aesthetic & Reconstructive Surgery. 2016. doi:10.4172/2472-1905.100013
BibTeX
@article{Shih2016,
author = {Shih, Hubert B and BS, Afaaf Shakir},
title = {Concurrent Skin Reduction in Nipple Sparing Mastectomy and Immediate Tissue Expander Reconstruction for Grade Three Ptosis Breasts},
journal = {Journal of Aesthetic & Reconstructive Surgery},
year = {2016},
doi = {10.4172/2472-1905.100013}
}
EUVIMED